← back to search

Vanessa Piechotta

Robert Koch Institute · DE
Area of research
Infectious Diseases · Statistics, Probability and Uncertainty
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Meta-analysis and systematic reviews, and Vaccine Coverage and Hesitancy.
h-index
26
citations
3,222
works
109
NIH funding
—
primary concept
Medicine
email
piechottav@rki.de

Recent publications

Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystem
Journal of Clinical Epidemiology 2024cited by 5position: middledoi
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
The Lancet Infectious Diseases 2023cited by 655position: middledoi
Automated Monitoring of Adherence to Evidenced-Based Clinical Guideline Recommendations: Design and Implementation Study
Journal of Medical Internet Research 2023cited by 19position: middledoi
Janus kinase inhibitors for the treatment of COVID-19
Cochrane Database of Systematic Reviews 2022cited by 50position: middledoi
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
Cochrane Database of Systematic Reviews 2022cited by 41position: middledoi
Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review
Cochrane Database of Systematic Reviews 2022cited by 21position: middledoi
Remdesivir for the treatment of COVID-19
Cochrane Database of Systematic Reviews 2021cited by 207position: middledoi
Vitamin D supplementation for the treatment of COVID-19: a living systematic review
Cochrane Database of Systematic Reviews 2021cited by 119position: lastdoi
Colchicine for the treatment of COVID-19
Cochrane Database of Systematic Reviews 2021cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Miriam Stegemann · Charité - Universitätsmedizin Berlin6 papers (2021–2022)Nicole Skoetz · Universitätsmedizin Göttingen6 papers (2021–2023)Agata Mikołajewska · Department of Science and Technology5 papers (2021–2022)— · 4 papers (2021–2022)— · 2 papers (2021–2022)— · 2 papers (2021–2022)Nina Kreuzberger · Gesundheitsamt2 papers (2022–2022)— · 2 papers (2022–2022)— · 2 papers (2021–2021)— · 2 papers (2021–2022)Anika Mueller · Charité - Universitätsmedizin Berlin2 papers (2021–2023)— · 2 papers (2022–2022)Falk Fichtner · Charité - Universitätsmedizin Berlin2 papers (2021–2022)Carina Benstoem · Medizinische Hochschule Hannover2 papers (2021–2021)— · 2 papers (2022–2022)— · 2 papers (2022–2022)— · 2 papers (2022–2022)Hanane Issa · University College London1 papers (2023–2023)Christoph D. Spinner · TUM Klinikum1 papers (2022–2022)Isabel Bergeri · World Health Organization1 papers (2023–2023)